| 摘要 |
A method of treating bone loss comprises co-administering therapeutically effective amounts of parathyroid hormone and a compound of formula (1) or a pharmaceutically acceptable salt thereof wherein R1 and R2 are independently selected from the group consisting of hydrogen and alkyl of one to six carbon atoms. The co-administration may take the mode of simultaneous, concurrent, or sequential administration of the two compounds.
|
